Many severely hypoxic cells fail to initiate DNA replication, but the mechanism underlying this observation is unknown. Specifically, although the ataxia-telangiectasia-rad3 related (ATR) kinase has been shown to be activated in hypoxic cells, several studies have not been able to document down-stream consequences of ATR activation in these cells. By clearly defining the DNA replication initiation checkpoint in hypoxic cells, we now demonstrate that ATR is responsible for activating this checkpoint. We show that the hypoxic activation of ATR leads to the phosphorylation-dependent degradation of the cdc25a phosphatase. Downregulation of cdc25a protein by ATR in hypoxic cells decreases CDK2 phosphorylation and activity, which results in the degradation of cdc6 by APC/ C Cdh1 . These events do not occur in hypoxic cells when ATR is depleted, and the initiation of DNA replication is maintained. We therefore present a novel mechanism of cdc6 regulation in which ATR can have a central role in inhibiting the initiation of DNA replication by the regulation of cdc6 by APC/C Cdh1 . This model provides insight into the biology and therapy of hypoxic tumors.
Introduction
A wide variety of solid and hematological malignancies contain severely hypoxic cells, with both animal and human studies documenting oxygen levels below 0.1% in up to 35% of tumors (Vaupel et al., 1991; Olive et al., 2002) . Hypoxic cells respond to this stress by a variety of transcriptional and posttranscriptional mechanisms, which result in an increase in glycolytic flux, a suppression of oxidative metabolism and protein translation, and an increase in angiogenesis and autophagy (reviewed in Gardner and Corn, 2008) . Hypoxic cells also adapt to their microenvironment by suppressing proliferation, a general phenomenon in non-transformed cells that is absent in several transformed cell lines (Schmaltz et al., 1998; Gardner et al., 2001 Gardner et al., , 2003 . Because the hypoxic activation of cell-cycle checkpoints may help to explain phenomena such as tumor dormancy, and the absence of these checkpoints in tumors may help to explain the poor prognosis of those with hypoxic tumors, the characteristics and mechanisms of the hypoxia-induced growth arrest have been intensively studied (reviewed in Green and Giaccia, 1998) .
The cell-cycle checkpoints activated in hypoxic cells vary depending on the extent of cellular hypoxia (which is both a function of the duration of hypoxia and the degree of hypoxia). In addition to a G1-cell-cycle arrest that occurs with moderate (B1% oxygen) hypoxia (Graeber et al., 1994; Gardner et al., 2001; Koshiji et al., 2004) , we and others have described a distinct S-phase arrest that occurs in severely hypoxic cells (Green et al., 2001; Gardner et al., 2003; Hammond et al., 2003b; Olcina et al., 2010) . Specifically, we noted that cell progression through S phase did not occur in hypoxic cells, but that the elongation component of DNA replication was not altered, suggesting that the initiation of DNA replication is defective in severely hypoxic cells. However, the mechanism underlying this S-phase checkpoint is unknown.
The normal initiation of DNA replication is a highly orchestrated event. Before DNA replication, pre-replicative complexes are formed by the recruitment of cdc6 to origins of replication, followed by the loading and phosphorylation of the minichromosome maintenance proteins (MCMs). cdc6 has a critical role in regulating DNA replication, as it is both limiting and essential for S-phase entry, and depletion of cdc6 inhibits new origin firing (Hateboer et al., 1998; Stoeber et al., 1998; Lau et al., 2006) . The CDK2 kinase phosphorylates cdc6 and prevents its degradation, therefore promoting prereplicative complex assembly (Cook et al., 2002; Mailand and Diffley, 2005) . Cdk2 kinase activity, in turn, is regulated by cyclin-dependent kinase inhibitors and the cdc25A phosphatase, which activates CDK2 (Mailand et al., 2000) . A variety of kinases, including CDK2 and Cdc7-Dbf4, phosphorylate MCM2 and promotes MCM helicase activity, which is also necessary for the initiation of DNA replication (Jiang et al., 1999; Montagnoli et al., 2006) . This initiation of DNA replication can be repressed by an S-phase checkpoint in response to a variety of cellular stresses. This checkpoint can be activated by either the ataxia telangectasia mutated (ATM) and/or the ATM-rad9 related (ATR) kinases. ATM activation occurs in response to double-strand DNA breaks, which occurs when hypoxic cells are reoxygenated, but is unlikely to be responsible for the S-phase checkpoint observed in pure hypoxic conditions (Hammond et al., 2003b) . In contrast, several studies have convincingly demonstrated that ATR is activated in hypoxic cells (Hammond et al., 2002 (Hammond et al., , 2003a . The activation of ATR in hypoxic cells is presumably due to the documented accumulation of single-strand DNA in hypoxic cells . Activation of ATR and its downstream target Chk1 have been demonstrated to have an important role in the S-phase checkpoint during UV irradiation, and indeed ATR has been described to promote the degradation of the cdc25a protein (Heffernan et al., 2002 (Heffernan et al., , 2007 Busino et al., 2003) . However, in hypoxic cells the depletion of ATR has been reported to not affect thymidine incorporation into DNA . In addition, several well-described consequences of ATR activation by other stresses (for example, UV irradiation) have not been observed in hypoxic cells. For example, although cdc25a is downregulated in hypoxic cells, this has been attributed to alterations in the transcript level, not ATR activation and cdc25a protein stability (Hammer et al., 2007; de Oliveira et al., 2009) . Thus the biological consequences of ATR activation in hypoxic cells are unknown.
Previous studies that have assessed the role of ATR activation in hypoxic cells have utilized conditions that markedly suppress general DNA replication . We reasoned that any participation of ATR to the inhibition of DNA replication would be best appreciated when the initiation of DNA replication, as opposed to other hypoxia-induced checkpoints, is suppressed. Therefore, we focused on those conditions which selectively inhibit the initiation of DNA replication and investigated both known and novel consequences of ATR activation, which contribute to regulating DNA replication in hypoxic cells, as well as the upstream events required for ATR activation in hypoxic cells.
Results

ATR participates in the hypoxic suppression of DNA replication
To identify the conditions in which the initiation of DNA replication is most affected in hypoxic cells, we pulsed hypoxic cells with tritiated thymidine to tag the ends of replicating DNA, and then separated nascent DNA molecules according to size in alkaline sucrose gradients. Lighter, smaller molecules represent those initiated during the pulse, and larger, heavier, fragments represent elongating fragments. This technique, for example, has demonstrated that low-dose UV irradiation inhibits the initiation of DNA replication, whereas higher doses suppress both DNA initiation and elongation (Kaufmann et al., 1980; Heffernan et al., 2002) . We noted a similar pattern in hypoxic cells, where cells rendered severely hypoxic for short periods of time selectively inhibited DNA replication initiation, and DNA synthesis in general was inhibited after longer periods of time ( Figure 1a ).
We therefore elected to focus further studies on DNA replication in cells rendered severely hypoxic for a relatively brief period, when initiation is most hampered. During this period we confirmed that a specific ATM substrate, Chk2, is not phosphorylated (Figure 1b ) but that the ATM/ATR targets rad17-serine 645 and p53-serine 15 are phosphorylated ( Figure 1c ). Caffeine, a non-selective inhibitor of both ATM and ATR attenuated these phosphorylation events (Figure 1c ). When cells were rendered hypoxic for short periods of time and then treated with caffeine, we also noted a restoration in the initiation component of DNA replication (Figure 1d ).
Several studies have specifically investigated, and have not found a role for ATR activation in hypoxia-induced cell-cycle arrests . In addition, caffeine has many effects in addition to the inhibition of ATR. We therefore used two separate strategies to specifically deplete ATR and assess the hypoxic suppression of DNA replication. Although complete deletion of ATR is incompatible with long-term proliferation, (Brown and Baltimore, 2000) we generated several shRNA sequences against ATR and identified one where we achieved B80% depletion of ATR in the osteosarcoma cell line, U2OS, without any gross effect on proliferation (1E). We also generated a system to express an inducible cre recombinase in previously described colon cancer HCT116 ATR flox/À cells (Cortez et al., 1999) ; cre induction led to a dramatic decrease in ATR expression in these cells after two days ( Figure 1f ). Compared with control hypoxic cells, the hypoxiainduced phosphorylation of Chk1-serine 345, a specific ATR target, was blunted in both U2OS and HCT116 cell lines after ATR expression was diminished ( Figure 1g ). When ATR depleted cells were rendered hypoxic for durations that impair the initiation of DNA replication, there was no significant suppression of DNA replication, in contrast to their respective matched control cells (Figure 1h ). Of note, under our conditions even the heterozygous HCT116 ATR flox/À cells, which express B15% of wild-type levels of ATR ( Figure 1f ) had marked deficiencies in the hypoxic phosphorylation of Chk1 compared with wild-type HCT116 cells ( Figure 1g ). In addition, there was no attenuation of DNA replication in hypoxic HCT116 ATR flox/À flox cells with or without cre induction (Figure 1h ), confirming that even moderate decreases of ATR can promote proliferation in hypoxic cells.
The hypoxic activation of ATR downregulates cdc25a and promotes CDK2 phosphorylation
We next sought to identify the mechanisms by which the activation of ATR suppresses the initiation of DNA replication in hypoxic cells. It should be noted that the activation of ATR in hypoxic cells does not necessarily have the same consequences as the activation of ATR in, for example, UV irradiated cells. For example, p53 is induced in hypoxic cells, but in contrast to its function in irradiated cells, hypoxia-induced p53 is neither transcriptionally active nor participates in any hypoxia-induced cell-cycle checkpoints (Graeber et al., 1994) . Similarly, although cdc25a protein has been well described to be degraded as a consequence of UV mediated ATR activation , the decrease in cdc25a protein expression in hypoxic cells has been attributed to transcriptional repression and/or RNA destabilization by a microRNA (Hammer et al., 2007; de Oliveira et al., 2009) .
However, when we examined hypoxic U2OS and HCT116 cells under conditions that selectively suppress the initiation of DNA replication in an ATR dependent manner, we noted a marked downregulation of cdc25a protein expression ( Figure 2a ) in the absence of a significant decrease in cdc25a mRNA expression ( Figure 2b) . A cdc25a construct without a 3 0 untranslated region expressed from an exogenous promoter was also downregulated in hypoxic cells, confirming that cdc25a is downregulated in a posttranscriptional mechanism ( Figure 2c ). In both U2OS and HCT116 cells cdc25a protein was not downregulated in the absence of ATR (Figure 2a ). Chk1 is known to phosphorylate cdc25a on serine 76, and cdc25a constructs which cannot be phosphorylated on this residue are not susceptible to ATR mediated destruction . Accordingly, we found that, in contrast to wild-type cdc25a, cdc25a S76A is stable when expressed in hypoxic cells (Figure 2c ). Cdc25a activates CDK2 by removing an inhibitory phosphate on CDK2 tyrosine 15 (Mailand et al., 2000) , so to determine the significance of cdc25a downregulation in hypoxic cells we assessed the phosphorylation status of CDK2. As expected, the phosphorylation of tyrosine 15 on cdk2 phosphorylation correlated to the level of cdc25a expression in hypoxic and normoxic cells. Specifically CDK2 tyrosine phosphorylation increased in hypoxic cells compared with normoxic cells, and this phosphorylation was diminished in hypoxic cells that expressed a cdc25a S76A, which is not degraded in hypoxic cells (Figure 2d ). Consistent with the stabilization of cdc25a in hypoxic ATR depleted cells, CDK2 phosphorylation was also diminished in hypoxic cells with ATR depletion, in contrast to control hypoxic cells (Figure 2e ). Finally, CDK2 activity also correlated to cdc25a expression and CDK2 tyrosine 15 phosphorylation status; it decreased in hypoxic cells and was de-repressed in hypoxic cells expressing a stable cdc25a ( Figure 2f ) and in hypoxic cells with ATR depletion (Figure 2g ). Together these data suggest that the hypoxic activation of ATR decreases CDK2 activity by phosphorylation and degradation of cdc25a.
The hypoxic activation of ATR leads to degradation of cdc6 by APC/C Cdh1 Although CDK2 has many substrates that have important roles in proliferation, we elected to focus on the hypoxic regulation of cdc6, a protein with a well-described role in the initiation of DNA replication. Both total (soluble) cdc6 and chromatin bound cdc6 protein expression decreased in hypoxic cells (Figure 3a ) in the absence of any decrease in cdc6 mRNA (Figure 3b ). This decrease in cdc6 protein expression was attenuated in hypoxic cells when ATR was depleted (Figures 3a and c) . CDK2 stabilizes cdc6 by phosphorylating cdc6 on several sites, including serine 106 (Mailand and Diffley, 2005) , and because of our data demonstrating a role for ATR in regulating CDK2 activity in hypoxic cells we examined the phosphorylation of cdc6 in hypoxic cells. The cdc6 serine 106 phosphorylation decreased in hypoxic cells, and along with a rescue of total cdc6 expression with the depletion of ATR, we noted a rescue of cdc6 serine 106 phosphorylation (Figure 3c ). In addition, in contrast to a wild-type cdc6 construct, expression of a cdc6 S54D, S74D, S106D phosphomimetic construct was stable in hypoxic cells (Figure 3d ).
To assess whether this hypoxia-induced, ATRmediated cdc6 downregulation was mediated by a decrease in CDK2 activity, we examined cdc6 expression in hypoxic cells expressing cdc25a S76A, which is stabilized in hypoxic cells and thus rescues CDK2 activity in hypoxic cells (Figure 2 ). The expression of this stable cdc25a in hypoxic cells phenocopied ATR depletion by stabilizing cdc6, thus suggesting that decreased CDK2 activity is responsible for the downregulation of cdc6 in hypoxic cells (Figure 3e) . These data suggest that in hypoxic cells the activation of ATR, downregulation of cdc25a, decrease in cdk2 activity, and diminished phosphorylation of cdc6, leads to cdc6 downregulation.
Downregulation of cdc6 was rescued by the treatment of hypoxic cells with a MG132, a proteasome inhibitor, suggesting that ATR led to the ubiqutination and degradation of cdc6 protein (Figure 3f ). Two ubiquitin ligases have been implicated in the degradation of cdc6, APC/C Cdh1 and Huwe1 (Mailand and Diffley, 2005; Hall et al., 2007) . Huwe1 has specifically found to degrade cdc6 with DNA damage (Hall et al., 2007) and APC/ C Cdh1 is thought to regulate cdc6 to prevent the rereplication of DNA (Mailand and Diffley, 2005) . Intiguingly, in addition to proteasome inhibition, cdc6 degradation was also inhibited by MLN, an inhibitor of neddylation that affects neither Huwe1 nor APC/C Cdh1 directly (Figure 3f ). However, MLN does lead to an accumulation of the APC/C Cdh1 inhibitor Emi1 (due to inhibition of btrcp/cul1) (Reimann et al., 2001; Guardavaccaro et al., 2003; Benmaamar and Pagano, 2005) . Consistent with this possibility, specific depletion of Huwe1 had no effect on the expression of cdc6 in hypoxic cells (3G, left panel), whereas the knock down of cdh1 blocked the downregulation of cdc6 in hypoxic cells (Figure 3g, right panel) .
Finally, we assessed the functional significance of cdc6 degradation in hypoxic cells. Expression of wild-type cdc6 partially rescued DNA replication in hypoxic cells (Figure 3h) , consistent with the previous report that high expression of even wild-type cdc6 can bind to chromatin, avoid degradation, and promote proliferation (Cook et al., 2002) . However, expression of the phosphomimetic cdc6 DDD mutant, stable in hypoxic cells, was sufficient to fully restore DNA replication in hypoxic cells (Figure 3h ). Together these data suggest that degradation of cdc6 by APC1 in hypoxic cells has a critical role in inhibiting the initiation of DNA replication.
MCM2 loading and phosphorylation is inhibited in hypoxic cells cdc6 has an important role on loading the MCM proteins into a replication complex, a process necessary for the initiation of DNA replication (Cook et al., 2002) . We therefore examined the extent of chromatin bound MCM2 in hypoxic cells, and the contribution the hypoxic activation of ATR plays in this loading. We noted that although total MCM2 was not greatly altered in hypoxic cells, the fraction of chromatin bound MCM2 was moderately decreased, and released into the nucleoplasm (Figure 4a ). This hypoxic downregulation of chromatin bound MCM2 was rescued in ATR depleted cells (Figure 4b) .
After recruitment of the MCM complex by cdc6, MCMs can be activated by phosphorylation on multiple sites by cdc7, CDK2 and CDK1, which activate MCM helicase activity (Montagnoli et al., 2006) . In xeonpus, ATR has been reported to decrease MCM2 phosphorylation by inhibition of the cdc7 kinase (Costanzo et al., 2003) whereas separate studies have indicated that ATR can directly phosphorylate MCM2 on serine 108 (Cortez et al., 2004) . When we fully resolved proteins with form of cdc6 were rendered hypoxic and assessed for cdc6 expression. Experiments were replicated and fold changes displayed (e) cdc6 protein expression in normoxic and hypoxic U2OS cells expressing wild-type cdc25a or a stable cdc25a S76A construct. Experiments were done in triplicate and fold changes displayed. (f) U2OS cells were rendered hypoxic or normoxic for 8 h, the last three with either MG132 (10 mM) or MLN, and cdc6 expression was assessed. (g) Normoxic and hypoxic U2OS cells were depleted for Huwe1 or cdh1 and cdc6 expression was assessed. Experiments were replicated and fold changes displayed (h). 293T cells, expressing either control plasmid, wild type or a phosphomimetic (DDD) form of cdc6 were rendered hypoxic and thymidine incorporation was assessed. Experiments were done in triplicate and average ± s.e. is displayed. electrophoresis, we noted that along with the decrease in chromatin bound MCM2 in hypoxic cells, there was a shift in mobility of the chromatin bound MCM2 (Figure 4b ) consistent with altered phosphorylation levels. Indeed phosphatase treatment caused MCM2 to migrate as a single band (Figure 4c ). This hypoxia dependent change in MCM2 mobility was rescued by depletion of ATR (Figure 4b) .
In order to get a better insight into the events required for MCM2 phosphorylation in hypoxic cells, we used phosphospecific MCM2 antibodies on normoxic and hypoxic control and ATR depleted cells. To simplify the comparisons, we utilized extracts from less severely hypoxic cells, where total chromatin bound MCM2 was not greatly altered (Figure 4d ). There was no dramatic difference in the phosphorylation status of serine 53 (which is cdc7 dependent) or serine 139 (which is thought to be cdc7 independent) in hypoxic cells (Figure 4d ). Although soluble serine 108 phosphorylated MCM2 was diminished with ATR depletion, the amount of chromatin bound serine 108 phosphorylated MCM2 was not dramatically altered in hypoxic cells (where ATR is activated). In contrast, chromatin bound MCM2 serine 40/41 phosphorylation was strongly decreased in hypoxic cells. This decrease of serine 40/ 41 was marginal in hypoxic ATR depleted cells, although the absence of ATR itself led to a dramatic decrease in serine 40/41 phosphorylation. The unaltered phosphorylation status of serine 53, as well as the stable expression of chromatin bound cdc7 in hypoxic cells, suggests that cdc7 kinase activity is not obviously altered in hypoxic cells, despite ATR activation. Thus the downregulation of Serine 40/41 phosphorylation in hypoxic cells could be either because of loss of a priming kinase that has been reported to be necessary for Cdc7dependent Serine 40 phosphorylation in vitro (Montagnoli et al., 2006) or hyper activation of a phosphatase acting on MCM2 Serine 40/41.
Discussion
Our studies indicate that the hypoxic activation of ATR has an important role in suppressing DNA replication, in large part through the degradation of cdc25a, resulting inactivation of CDK2 activity, and the downregulation of cdc6 via APC/cdh1-mediated degradation ( Figure 5) . The central role for the hypoxic down- Hypoxic activation of ATR L Martin et al regulation of cdc6 in the inhibition of DNA replication is demonstrated by the restoration of DNA replication in hypoxic cells expressing a stable cdc6. Although APC/C Cdh1 has been referred to as the master controller origin licensing (Sivaprasad et al., 2007) , the important link between ATR activation, APC/C Cdh1 , and cdc6 has not previously been appreciated. Our clear documentation that APC/cdh1 has an important role in the initiation of DNA replication in hypoxic cells, emphasizes both the well known regulation of ubiqutin/ proteasome system in hypoxic cells and the established of this system in controlling the cell cycle. Indeed, APC/ C Cdh1 regulation by Emi1 has been found to be particularly important for the physiological regulation of the initiation of DNA replication . The fact that, in contrast to the events seen in DNA damage, Huwe1 is not responsible for degrading cdc6 in hypoxic cells, highlights the important differences between the cellular response to hypoxic stress and to DNA damage.
Although previous studies have demonstrated diminished CDK2 activity and decreased cdc25a expression in hypoxic cells, the mechanisms for these observations did not include a role for ATR (Gardner et al., 2001; Green et al., 2001; Koshiji et al., 2004; Hammer et al., 2007; de Oliveira et al., 2009) . Indeed, deletion of ATR was previously not found to have a role in the proliferation of hypoxic cells . These discrepancies are best resolved by noting that our studies focused on conditions in which the initiation of DNA replication is most affected. For example, during the hypoxic conditions we utilized, total thymidine incorporation decreased 40-50%, whereas previous studies used conditions, which suppressed total thymidine incorporation up to 90% , suggesting the strategies used in those studies rendered cells more hypoxic and almost completely ceased proliferation. Accordingly, we have previously noted (Gardner et al., 2003) that the duration and degree of cellular hypoxia can result in the activation of distinct checkpoints, as confirmed from our experiments here. For example, moderate hypoxia does not result in activation of ATR, and prolonged hypoxia is expected to result in decreased transcriptional activation of cdc25a because of hypophosphorylation of the Rb protein and decreased E2F expression (Vigo et al., 1999; Gardner et al., 2001 Gardner et al., , 2003 .
We did not observe any tumor growth in nude mice injected subcutaneously with control U2OS cells, U2OS cells with cdc6 wild-type overexpression, U2OS cells with cdc6 DDD overexpression, U2OS cells with cdc25a overexpression or cdc25a S76A overexpression (data not shown). This observation suggests that manipulation of the cdc25a or cdc6 pathways is not sufficient to promote tumorigenesis, a finding readily explained by the metabolic, angiogenic and many other pathways that need to be activated to support three dimensional tumor growth. In HCT116 cells manipulated to express the above constructs (Supplementary Figure S1A ) the manipulation of cdc25a or cdc6 did not have a significant effect on cell proliferation in tissue culture (that is, not hypoxic) (Supplementary Figure S1B ), or in tumorigenesis in nude mice (Supplementary Figure  S1C) . Thus the manipulation of the ATR downstream pathway alone cannot alter growth in hypoxic xenografts, again consistent with the complex requirements for three-dimensional tumor growth (which include the bypass of several distinct cell-cycle checkpoints, we and others have described). Thus additional studies, including the assessment of ATR activation, cdc25a expression and activity of the DNA replication complex in hypoxic regions of tumors, are required to fully determine the biological relevance of our findings.
However, because many tumors contain areas of severely hypoxic cells, and because ATR and downstream targets including cdc6 and cdc25a have been both noted to be dysregulated in cancer and to be targets for cancer therapy (Borlado and Mendez, 2008) , the hypoxic regulation of ATR is likely to have biological and therapeutic implications in cancer. The de-regulation of ATR signaling would be expected to allow at least the initiation of DNA replication to occur in hypoxic cancer cells. We and others have noted that some malignant cells have the capacity to proliferate, despite being rendered severely hypoxic (Gardner et al., 2003) . Oncoproteins have been reported to activate cdc6 (Sotillo et al., 2009) , and indeed we have determined that overexpression of the E1a oncoprotein allows hypoxic cells to proliferate (Gardner et al., 2003) . Finally, our current studies demonstrate that activation of ATR in hypoxic cells leads to the degradation of cdc6 by APC/C Cdh1 , and this is inhibited by both proteasome inhibitors, as well as inhibitors of neddylation, two classes of agents that have been proven clinically active in a variety of malignancies. Although bypass of hypoxic checkpoints could permit cancers to escape a dormant state, it is possible that the therapeutic manipulation of these checkpoints could render cells more prone to death from a hostile microenvironment, or from proliferation dependent therapeutics. 
Materials and methods
Cell lines U2OS, HCT116 and 293 cell lines were obtained from ATCC. U2OS cells were maintained in DMEM, 10% fetal calf serum, and HCT116 and HCT116 ATR flox/À (Zou and Elledge, 2003) were cultured in McCoy's 5A containing Geneticin (G418). Cells were incubated at 37 1C in 5% CO 2 and room air (standard tissue culture incubator) or in a Plas-Labs environmental chamber with 5% CO 2 and o0.1% oxygen. HCT116 ATR flox/À cells were infected with a tamoxifen inducible pBABE-Cre recombinase retrovirus, and for cre was induced with 40 mM tamoxifen for 48 h before experimentation.
Plasmids cdc25a wild type and S76A mutated plasmids were cloned into the retroviral construct pQCXIN. pCDNA3.1 expressing Cdc6 wild type and DDD mutants have been described (Mailand and Diffley, 2005) . Hairpin sequences directed against ATR were derived computationally and cloned into the pSUPER retrovirus; the sequence 5 0 -GAGCT TACCTTGCGTAGGGC-3 0 was deemed most effective and utilized. LKO.1 shRNA lentiviruses directed against Huwe1 (TRCN73306) and APC/C Cdh1 (TRCN231902) were obtained from Sigma.
Retroviral generation and transfections
Cdc6 vectors were transfected into 293T cells with calcium phosphate. Retroviruses and lentiviruses were generated as previously reported (Martin et al., 2010) . For APC/C Cdh1 knock-down experiments, cells were infected twice with lentivirus over 12 h and experiments were performed 24 h later.
Immunoblots
Whole cell extracts were prepared as previously reported (Martin et al., 2010) . Complete compartmental extraction experiments were performed as reported (Mendez and Stillman, 2000) . For soluble and insoluble chromatin bound fractionation, cells were suspended in CSK buffer containing 0.5% Triton X-100, 10 mM Pipes pH 6.8, 100 mM NaCl, 1.5 mM MgCl 2 , 300 mM sucrose, 1 mM of protease inhibitors, 1 mM PMSF, 10 mM NaF and 1 mM ATP, incubated on ice for 15 mins and then centrifuged at 3200 rpm. The supernatant containing soluble protein and the pellet containing insoluble chromatin bound protein were separated and resuspended in equal volumes of 2X Laemelli buffer, membranes were blocked and probed as described previously (Martin et al., 2010) with antibodies for ATR (A300-138A, Bethyl laboratories, Inc., Montgomery, TX, USA), CHK1 (sc-7898), phosphor CHK1, Cdc25A (sc-7157), Cdk2 (sc-163), p-Cdc2 p34 (Thr14/ Tyr15)(sc-12340), Cdc6 (sc-9964), Huwe1, Cdh1, Flag (F1804, Sigma), HA (H6908, Sigma), Tubulin (T9026, Sigma), Chk1-Serine 345, Rad17 ser645, p53 serine 15 and H2AX serine 139 were obtained from Cell Signaling, Danvers, MA, USA. Antiphospho MCM2 antibodies were previously described (Montagnoli et al., 2006) .
Real-time PCR
RNA was isolated, cDNA prepared, and real-time PCR performed as previously described (Martin et al., 2010) . Cdc25a primers were F: 5 0 -ACCGTCACTATGGACCAGC-3 0 and R: 5 0 -TTCAGACTGGACTACATC-3 0 . cdc6 primers were F: 5 0 -CTTAAGCCGGATTCTGCAAG-3 0 and R: 5 0 -CAGT CCTCAAGGACATGCAA-3 0 .
Thymidine incorporation assay Cells (300 000/35 mM) were split 24 h prior to a change to fresh media and either normoxic or hypoxic incubation. After cells were incubated for 7 h, they were pulse labeled with media (or deoxygenated media) containing 3 H-Thymidine (30 mCi/ml) for 15 min. Cells were then washed with ice cold PBS and lysed (although normoxic or hypoxic) with 1 M NaOH. DNA was precipitated with salmon testes and 1 ml 17% TCA, precipitated DNA was filtered through GF/C Whatman 24 mm filters, and 3 H-Thymidine was counted.
Alkaline sucrose gradient analysis Hypoxic and normoxic cells were pulsed with 3 H-Thymidine and fractionated on a sucrose gradient as reported (Heffernan et al., 2002) .
In vitro kinase assay CDK2 was immunoprecipitated from cells and H1 kinase activity was assessed as previously reported (Gardner et al., 2001) .
